Mitragynine is the major alkaloid of Mitragyna speciosa (kratom) with potential as a therapeutic in pain management and in depression. There has been debate over the potential side effects of the drug including addiction risk and cognitive decline.
Aims:
To evaluate the effects of mitragynine on neurophysiological systems function in the prefrontal cortex (PFC), cingulate cortex (Cg), orbitofrontal cortex, nucleus accumbens (NAc), hippocampus (HIP), thalamus (THAL), basolateral amygdala (BLA) and ventral tegmental area of rats.
Methods:
Local field potential recordings were taken from animals at baseline and for 45 min following mitragynine administration (10 mg/kg, intraperitoneally). Drug-induced changes in spectral power and coherence between regions at specific frequencies were evaluated. Mitragynine-induced changes in c-fos expression were also analyzed.
Results:
Mitragynine increased delta power and reduced theta power in all three cortical regions that were accompanied by increased c-fos expression. A transient suppression of gamma power in PFC and Cg was also evident. There were no effects of mitragynine on spectral power in any of the other regions. Mitragynine induced a widespread reduction in theta coherence (7–9 Hz) that involved disruptions in cortical and NAc connectivity with the BLA, HIP and THAL.
Conclusions:
These findings show that mitragynine induces frequency-specific changes in cortical neural oscillatory activity that could potentially impact cognitive functioning. However, the absence of drug effects within regions of the mesolimbic pathway may suggest either a lack of addiction potential, or an underlying mechanism of addiction that is distinct from other opioid analgesic agents.
Ahmadi SoleimaniSMMohamadiMAHMRaoufyMR, et al. (2018) Acute morphine administration alters the power of local field potentials in mesolimbic pathway of freely moving rats: Involvement of dopamine receptors. Neurosci Lett686: 168–174.
2.
ApryaniEHidayatMTMoklasMAA, et al. (2010) Effects of mitragynine from Mitragyna speciosa Korth leaves on working memory. J Ethnopharmacol129: 357–360.
3.
AveryBABodduSPSharmaA, et al. (2019) Comparative pharmacokinetics of mitragynine after oral administration of Mitragyna speciosa (Kratom) leaf extracts in rats. Planta Med85: 340–346.
4.
BjorkMHSandTBråthenG, et al. (2008) Quantitative EEG findings in patients with acute, brief depression combined with other fluctuating psychiatric symptoms: A controlled study from an acute psychiatric department. BMC Psychiatry8: 89.
5.
BohnLMGainetdinovRRLinFT, et al. (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature408: 720–723.
6.
BrolinEZellerothSJonssonA, et al. (2018) Chronic administration of morphine using mini-osmotic pumps affects spatial memory in the male rat. Pharmacol Biochem Behav167: 1–8.
7.
Canadian Council on Animal Care (1993) Guide to the Care and Use of Experimental Animals. 2nd ed, Vol. 1. Ottawa, ON.
8.
CheahaDReakkamnuanCNukitramJ, et al. (2017) Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice. J Ethnopharmacol208: 129–137.
9.
FingelkurtsAKahkonenSFingelkurtsA, et al. (2008) Reorganization of the composition of brain oscillations and their temporal characteristics during opioid withdrawal. J Psychopharmacol22: 270–284.
10.
Foute NelongTManducaJDZonneveldPM, et al. (2019) Asenapine maleate normalizes low frequency oscillatory deficits in a neurodevelopmental model of schizophrenia. Neurosci Lett711: 134404.
11.
HakamiTJonesNCTolmachevaEA, et al. (2009) NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness. PLoS One4: e6755.
12.
HarunNHassanZNavaratnamV, et al. (2015) Discriminative stimulus properties of mitragynine (kratom) in rats. Psychopharmacology (Berl)232: 2227–2238.
13.
HarunNJohariISMansorSM, et al. (2019) Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats. Psychopharmacology (Berl). Epub ahead of print 14 December 2019. DOI: 10.1007/s00213-019-05418-6.
14.
HasbiAPerreaultMLShenMYF, et al. (2017) Activation of dopamine D1-D2 receptor complex attenuates cocaine reward and reinstatement of cocaine-seeking through inhibition of DARPP-32, ERK, and DeltaFosB. Front Pharmacol8: 924.
15.
HassanZSuhaimiFWRamanathanS, et al. (2019) Mitragynine (Kratom) impairs spatial learning and hippocampal synaptic transmission in rats. J Psychopharmacol33: 908–918.
16.
HazimAIMuzaimiMMansorSM (2011) The effects on motor behaviour and short-term memory tasks in mice following an acute administration of Mitragyna speciosa alkaloid extract and mitragynine. J Med Plants Res5: 5810–5817.
17.
HazimAIRamanathanSParthasarathyS, et al. (2014) Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats. J Physiol Sci64: 161–169.
18.
HembySEMcIntoshSLeonF, et al. (2019) Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine. Addict Biol24: 874–885.
19.
HiranitaTLeonFFelixJS, et al. (2019) The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats. Psychopharmacology (Berl)236: 2725–2734.
20.
HuntMJRaynaudBGarciaR (2006) Ketamine dose-dependently induces high-frequency oscillations in the nucleus accumbens in freely moving rats. Biol Psychiatry60: 1206–1214.
21.
IdayuNFHidayatMTMoklasMAM, et al. (2011) Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression. Phytomedicine18: 402–407.
22.
IsmailIWahabSSidiH, et al. (2019) Kratom and future treatment for the opioid addiction and chronic pain: periculo beneficium?Curr Drug Targets20: 166–172.
23.
IsmailNIWJayabalanNMansorSM, et al. (2017) Chronic mitragynine (kratom) enhances punishment resistance in natural reward seeking and impairs place learning in mice. Addict Biol22: 967–976.
24.
KambleSHSharmaAKingTI, et al. (2019) Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom). Xenobiotica49: 1279–1288.
25.
KruegelACGassawayMMKapoorA, et al. (2016) Synthetic and receptor signaling explorations of the mitragyna alkaloids: Mitragynine as an atypical molecular framework for opioid receptor modulators. J Am Chem Soc138: 6754–6764.
26.
KruegelACGrundmannO (2018) The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology134(Pt A): 108–120.
27.
KruegelACUpretyRGrinnellSG, et al. (2019) 7-hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects. ACS Cent Sci5: 992–1001.
28.
KumarnsitEKeawpradubNNuankaewW (2007) Effect of Mitragyna speciosa aqueous extract on ethanol withdrawal symptoms in mice. Fitoterapia78: 182–185.
29.
LiuNLiuYFanY, et al. (2005) EEG activities in the orbitofrontal cortex and dorsolateral prefrontal cortex during the development of morphine dependence, tolerance and withdrawal in rhesus monkeys. Brain Res1053(1–2): 137–145.
30.
LuGZhouQXKangS, et al. (2010) Chronic morphine treatment impaired hippocampal long-term potentiation and spatial memory via accumulation of extracellular adenosine acting on adenosine A1 receptors. J Neurosci30: 5058–5070.
31.
McVoyMAebiMELoparoK, et al. (2019) Resting-state quantitative electroencephalography demonstrates differential connectivity in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol29: 370–377.
32.
ManningCEWilliamsESRobisonAJ (2017) Reward network immediate early gene expression in mood disorders. Front Behav Neurosci11: 77.
33.
MatsumotoKMizowakiMSuchitraT, et al. (1996) Antinociceptive action of mitragynine in mice: Evidence for the involvement of supraspinal opioid receptors. Life Sci59: 1149–1155.
34.
MatsumotoKMizowakiMTakayamaH, et al. (1997) Suppressive effect of mitragynine on the 5-methoxy-N,N-dimethyltryptamine-induced head-twitch response in mice. Pharmacol Biochem Behav57(1–2): 319–323.
35.
MorganMLWitteEACookIA, et al. (2005) Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology52: 71–76.
36.
NegusSSFreemanKB (2018) Abuse potential of biased mu opioid receptor agonists. Trends Pharmacol Sci39: 916–919.
37.
NestlerEJ (2015) FosB: A transcriptional regulator of stress and antidepressant responses. Eur J Pharmacol753: 66–72.
38.
NodaYZomorrodiRSaekiT, et al. (2017) Resting-state EEG gamma power and theta-gamma coupling enhancement following high-frequency left dorsolateral prefrontal rTMS in patients with depression. Clin Neurophysiol128: 424–432.
39.
PalopJJMuckeL (2016) Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci17: 777–792.
40.
PizzagalliDAPeccoraloLADavidsonRJ, et al. (2006) Resting anterior cingulate activity and abnormal responses to errors in subjects with elevated depressive symptoms: A 128-channel EEG study. Hum Brain Mapp27: 185–201.
41.
ProzialeckWCJivanJKAndurkarSV (2012) Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects. J Am Osteopath Assoc112: 792–799.
42.
ReakkamnuanCCheahaDKumarnsitE (2017) Nucleus accumbens local field potential power spectrums, phase-amplitude couplings and coherences following morphine treatment. Acta Neurobiol Exp (Wars)77: 214–224.
43.
SabetghadamARamanathanSMansorSM (2010) The evaluation of antinociceptive activity of alkaloid, methanolic, and aqueous extracts of Malaysian Mitragyna speciosa Korth leaves in rats. Pharmacognosy Res2: 181–185.
44.
SauerJFStruberMBartosM (2015) Impaired fast-spiking interneuron function in a genetic mouse model of depression. Elife4: e04979.
45.
SenikMHMansorSMTharakanKJJ, et al. (2012) Effect of acute administration of Mitragyna speciosa Korth. Standardized methanol extract in animal model of learning and memory. J Med Plants Res6: 1007–1014.
46.
ShimMImCHKimYW, et al. (2018) Altered cortical functional network in major depressive disorder: A resting-state electroencephalogram study. Neuroimage Clin19: 1000–1007.
47.
TahaSMaloney-HallBBuxtonJ (2019) Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy. Subst Abuse Treat Prev Policy14: 32.
48.
TakayamaHIshikawaHKuriharaM, et al. (2002) Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: Discovery of opioid agonists structurally different from other opioid ligands. J Med Chem45: 1949–1956.
49.
ThériaultRKManducaJDPerreaultML (2019) Sex differences in innate and adaptive neural oscillatory patterns predict resilience and susceptibility to chronic stress in rats. bioRxiv. DOI: 10.1101/720011.
50.
VaradiAMarroneGFPalmerTC, et al. (2016) Mitragynine/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit beta-arrestin-2. J Med Chem59: 8381–8397.
51.
VialouVBagotRCCahillME, et al. (2014) Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of DeltaFosB. J Neurosci34: 3878–3887.
52.
YueKKopajticTAKatzJL (2018) Abuse liability of mitragynine assessed with a self-administration procedure in rats. Psychopharmacology (Berl)235: 2823–2829.
53.
YusofSRMohd UzidMTehEH, et al. (2019) Rate and extent of mitragynine and 7-hydroxymitragynine blood-brain barrier transport and their intra-brain distribution: The missing link in pharmacodynamic studies. Addict Biol24: 935–945.
54.
YusoffNHSuhaimiFWVadiveluRK, et al. (2016) Abuse potential and adverse cognitive effects of mitragynine (kratom). Addict Biol21: 98–110.
55.
YusoffNHMMansorSMMullerCP, et al. (2017) Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats. Behav Brain Res332: 1–6.
56.
ZhuZYeZWangH, et al. (2019) Theta-gamma coupling in the prelimbic area is associated with heroin addiction. Neurosci Lett701: 26–31.
57.
ZuoYFWangJYChenJH, et al. (2007) A comparison between spontaneous electroencephalographic activities induced by morphine and morphine-related environment in rats. Brain Res1136: 88–101.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
